| Authors: |
Herchenhorn D; Oncologia DOr/IDOR, Rio de Janeiro, Brazil.; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil., Abboud H; Oncologia DOr/IDOR, Rio de Janeiro, Brazil.; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil., Freire V; Oncologia DOr/IDOR, Rio de Janeiro, Brazil., Tarouquella J; Oncologia DOr/IDOR, Rio de Janeiro, Brazil., Monteiro FSM; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil.; Hospital Sírio-Libanês, Brasília, Brazil., Fay AP; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil.; Escola de Medicina da PUCRS, Hospital Nora Teixeira, Porto Alegre, Brazil., Freitas JLR; Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil., Mckay RR; University of California, San Diego, La Jolla, CA., Rose B; University of California, San Diego, La Jolla, CA., Carvalhal GF; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil.; Escola de Medicina da PUCRS, Hospital Nora Teixeira, Porto Alegre, Brazil., Morbeck I; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil.; Oncolinicas & CO, Sao Paulo, Brazil., Maluf FC; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, Brazil., Souza VC; Oncologia DOr/IDOR, Rio de Janeiro, Brazil.; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil., Valverde D; Healthtech Solutions, TechTrials, Sao Paulo, Brazil., Firmino EF; Healthtech Solutions, TechTrials, Sao Paulo, Brazil., Sasse AD; Grupo SONHE, Campinas, Brazil., Bastos D; Latin America Cooperative Oncology Group (LACOG)-Genitourinary Tumors, Porto Alegre, Brazil., James N; Institute of Cancer Research, London, UK. |
